4,743
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

Comparative efficacy and safety of anticoagulants for prevention of venous thromboembolism after hip and knee arthroplasty

A network meta-analysis

, , , , , , , & show all
Pages 634-641 | Received 18 Feb 2017, Accepted 22 Jun 2017, Published online: 08 Aug 2017

  • Ageno W, Eikelboom J, Lip G Y. Dabigatran in clinical practice: Contemporary overview of the evidence. Int J Cardiol 2016; 220: 417–28.
  • Baker S G, Kramer B S. The transitive fallacy for randomized trials: if A bests B and B bests C in separate trials, is A better than C? BMC Med Res Methodol 2002; 2: 13.
  • Cao Y B, Zhang J D, Shen H, Jiang Y Y. Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: A meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 2010; 66 (11): 1099–108.
  • Chaimani A, Higgins J P, Mavridis D, Spyridonos P, Salanti G. Graphical tools for network meta-analysis in STATA. PLoS One 2013; 8 (10): e76654.
  • Cohen A, Drost P, Marchant N, Mitchell S, Orme M, Rublee D, Simon T A, Sutton A. The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: Systematic review and network meta-analysis. Clin Appl Thromb Hemost 2012; 18 (6): 611–27.
  • Dahl O E, Quinlan D J, Bergqvist D, Eikelboom J W. A critical appraisal of bleeding events reported in venous thromboembolism prevention trials of patients undergoing hip and knee arthroplasty. J Thromb Haemost 2010; 8 (9): 1966–75.
  • Falck-Ytter Y, Francis C W, Johanson N A, Curley C, Dahl O E, Schulman S, Ortel T L, Pauker S G, Colwell Jr C W. Prevention of VTE in orthopedic surgery patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2, Supplement): e278S–e325S.
  • Fuji T, Wang C J, Fujita S, Kawai Y, Nakamura M, Kimura T, Ibusuki K, Ushida H, Abe K, Tachibana S. Safety and efficacy of edoxaban, an oral factor Xa inhibitor, versus enoxaparin for thromboprophylaxis after total knee arthroplasty: The STARS E–3 trial. Thromb Res 2014; 134 (6): 1198–204.
  • Fuji T, Fujita S, Kawai Y, Nakamura M, Kimura T, Fukuzawa M, Abe K, Tachibana S. Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V. Thromb J 2015; 13: 27.
  • Gomez-Outes A, Terleira-Fernandez A I, Suarez-Gea M L, Vargas-Castrillon E. Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: Systematic review, meta-analysis, and indirect treatment comparisons. BMJ 2012; 344: e3675.
  • Harenberg J, Marx S, Dahl O E, Marder V J, Schulze A, Wehling M, Weiss C. Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery. Thromb Haemost 2012; 108 (5): 903–12.
  • Higgins J P T, Green S, eds. Cochrane handbook for systematic reviews of interventions (Version 5.1.0) [Updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
  • Huang J, Cao Y, Liao C, Wu L, Gao F. Apixaban versus enoxaparin in patients with total knee arthroplasty: A meta-analysis of randomised trials. Thromb Haemost 2011; 105 (2): 245–53.
  • Hull R D, Yusen R D, Bergqvist D. State-of-the-art review: Assessing the safety profiles of new anticoagulants for major orthopedic surgery thromboprophylaxis. Clin Appl Thromb Hemost 2009; 15 (4): 377–88.
  • Jorgensen C C, Kehlet H. Thromboembolic and major bleeding events in relation to perioperative bridging of vitamin K antagonists in 649 fast-track total hip and knee arthroplasties. Acta Orthop 2017; 88 (1): 55–61.
  • Kapoor A, Ellis A, Shaffer N, Gurwitz J, Chandramohan A, Saulino J, Ishak A, Okubanjo T, Michota F, Hylek E, Trikalinos T A. Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis. J Thromb Haemost 2017; 15 (2): 284–94.
  • Li D, Wang T, Shen S, Cheng S, Yu J, Zhang Y, Zhang C, Tang H. Effects of fluoroquinolones in newly diagnosed, sputum-positive tuberculosis therapy: A systematic review and network meta-analysis. PLoS One 2015; 10 (12): e0145066.
  • Maratea D, Fadda V, Trippoli S, Messori A. Prevention of venous thromboembolism after major orthopedic surgery: Indirect comparison of three new oral anticoagulants. J Thromb Haemost 2011; 9 (9): 1868–70.
  • Miyagi J, Funabashi N, Suzuki M, Asano M, Kuriyama T, Komuro I, Moriya H. Predictive indicators of deep venous thrombosis and pulmonary arterial thromboembolism in 54 subjects after total knee arthroplasty using multislice computed tomography in logistic regression models. Int J Cardiol 2007; 119 (1): 90–4.
  • Moher D, Liberati A, Tetzlaff J, Altman D G, Group P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 2009; 339: b2535.
  • Neumann I, Rada G, Claro J C, Carrasco-Labra A, Thorlund K, Akl E A, Bates S M, Guyatt G H. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: A systematic review and meta-analysis. Ann Intern Med 2012; 156 (10): 710–19.
  • Sardar P, Chatterjee S, Lavie C J, Giri J S, Ghosh J, Mukherjee D, Lip G Y. Risk of major bleeding in different indications for new oral anticoagulants: Insights from a meta-analysis of approved dosages from 50 randomized trials. Int J Cardiol 2015; 179: 279–87.
  • Song F, Altman D G, Glenny A M, Deeks J J. Validity of indirect comparison for estimating efficacy of competing interventions: Empirical evidence from published meta-analyses. BMJ 2003; 326 (7387): 472.
  • Turun S, Banghua L, Yuan Y, Zhenhui L, Ying N, Jin C. A systematic review of rivaroxaban versus enoxaparin in the prevention of venous thromboembolism after hip or knee replacement. Thromb Res 2011; 127 (6): 525–34.
  • Venker B T, Ganti B R, Lin H, Lee E D, Nunley R M, Gage B F. Safety and efficacy of new anticoagulants for the prevention of venous thromboembolism after hip and knee arthroplasty: A meta-analysis. J Arthroplasty 2017; 32(2): 645–52.
  • White R H, Zhou H, Romano P S. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost 2003; 90 (3): 446–55.
  • White I R, Barrett J K, Jackson D, Higgins J P. Consistency and inconsistency in network meta-analysis: Model estimation using multivariate meta-regression. Res Synth Methods 2012; 3 (2): 111–25.
  • Yoshida Rde A, Yoshida W B, Maffei F H, El Dib R, Nunes R, Rollo H A. Systematic review of randomized controlled trials of new anticoagulants for venous thromboembolism prophylaxis in major orthopedic surgeries, compared with enoxaparin. Ann Vasc Surg 2013; 27 (3): 355–69.